1-4 of 4
Thomas Weimer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic Properties of Different rFVIII Products in Rabbits, Rats and FVIII Ko Mice

Sabine Pestel, DVM, Philipp Claar, Dr rer nat, Jochen Müller-Cohrs, Dr rer nat, Elmar Raquet, Hendrik Peil, Thomas Weimer, Dr rer nat, Eva Herzog, PhD
Journal: Blood
Blood (2015) 126 (23): 1078.
https://doi.org/10.1182/blood.V126.23.1078.1078
Published: 2015
Journal Articles

Pre-Clinical Characteristics of a Recombinant Fusion Protein Linking Activated Coagulation Factor VII with Albumin (rVIIa-FP)

Sabine Zollner, Daniel Schuermann, Elmar Raquet, Jochen Mueller-Cohrs, Thomas Weimer, Ingo Pragst, Gerhard Dickneite, Prof. PhD, Stefan Schulte, PhD
Journal: Blood
Blood (2012) 120 (21): 1115.
https://doi.org/10.1182/blood.V120.21.1115.1115
Published: 2012
Journal Articles

Prolonged In-Vivo Half-Life of FVIIa by Fusion to Albumin.

Stefan Schulte, PhD, Thomas Weimer, PhD, Wilfried Wormsbaecher, Ulrich Kronthaler, PhD, Albrecht Groener, PhD, Wiegand Lang, Uwe Liebing
Journal: Blood
Blood (2007) 110 (11): 3142.
https://doi.org/10.1182/blood.V110.11.3142.3142
Published: 2007
Journal Articles

Generation of Factor VIII Molecules Partially Resistant to Activated Protein C.

Veronique Rolli, Ph D, Nathalie Enjolras, PhD, Cecile Ducasse, Marie-Helene Rodriguez, PhD, Thomas Weimer, PhD, Hans-Peter Hauser, PhD, Claude Negrier, MD, PhD, Jean-Luc Plantier, Ph D
Journal: Blood
Blood (2004) 104 (11): 1729.
https://doi.org/10.1182/blood.V104.11.1729.1729
Published: 2004